Product Name

  • Name

    Solifenacin

  • EINECS
  • CAS No. 242478-37-1
  • Article Data40
  • CAS DataBase
  • Density 1.24 g/cm3
  • Solubility
  • Melting Point
  • Formula C23H26N2O2
  • Boiling Point 505.5 °C at 760 mmHg
  • Molecular Weight 362.472
  • Flash Point 259.5 °C
  • Transport Information
  • Appearance
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 242478-37-1 (Solifenacin)
  • Hazard Symbols
  • Synonyms Solifenacin;[(8R)-1-azabicyclo[2.2.2]octan-8-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate;2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-,1-azabicyclo(2.2.2)oct-3-yl ester, (R-(R*,S*))-;Solifenacin [inn:ban];Unii-A8910sqj1u;3,4-dihydro-1-phenyl-(1S)-2(1H)-Isoquinolinecarboxylic acid (3R)-1-azabicyclo[2.2.2]oct-3-yl ester;YM 905;(1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate
  • PSA 32.78000
  • LogP 3.74070

Synthetic route

C34H29NO2P(1+)*Cl(1-)

C34H29NO2P(1+)*Cl(1-)

(R)-quinuclidin-3-ol
25333-42-0

(R)-quinuclidin-3-ol

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
In toluene at 60 - 70℃; Temperature;96.8%
(S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180468-42-2

(S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline

(R)-quinuclidin-3-ol
25333-42-0

(R)-quinuclidin-3-ol

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
With sodium hydride; 1-butyl-3-methylimidazolium Tetrafluoroborate In N,N-dimethyl-formamide at 100℃; for 6h; Temperature; Concentration;95.1%
With sodium hydride In toluene for 3h; Heating;89%
Stage #1: (R)-quinuclidin-3-ol With sodium hydride In toluene; mineral oil at 0℃; for 0.25h; Inert atmosphere;
Stage #2: (S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline In toluene; mineral oil at 130℃; for 8h; Inert atmosphere; Dean-Stark;
88%
(3S)-1-azabicyclo[2.2.2]octan-3-yl 1H-imidazole-1-carboxylate

(3S)-1-azabicyclo[2.2.2]octan-3-yl 1H-imidazole-1-carboxylate

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8, 96719-89-0, 118864-75-8

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; for 2h; Inert atmosphere;92.2%
(3R)-1-azabicyclo[2,2,2]oct-3-yl pentafluorophenylcarbonate
1459721-13-1

(3R)-1-azabicyclo[2,2,2]oct-3-yl pentafluorophenylcarbonate

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8, 96719-89-0, 118864-75-8

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
In toluene at 10 - 15℃; Temperature; Time; Solvent;91%
In toluene at 10 - 15℃; Solvent; Temperature;91%
Solifenacin hydrochloride

Solifenacin hydrochloride

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
With ammonium hydroxide In water pH=9 - 10;90%
4-nitrophenyl (1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate
1229227-22-8

4-nitrophenyl (1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate

(R)-quinuclidin-3-ol
25333-42-0

(R)-quinuclidin-3-ol

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
Stage #1: (R)-quinuclidin-3-ol With 18-crown-6 ether; sodium hydride In toluene; mineral oil Inert atmosphere;
Stage #2: 4-nitrophenyl (1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate In toluene; mineral oil at 20 - 110℃; for 18h; Inert atmosphere;
74%
Stage #1: (R)-quinuclidin-3-ol With sodium hydride In N,N-dimethyl-formamide; mineral oil Inert atmosphere;
Stage #2: 4-nitrophenyl (1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate In N,N-dimethyl-formamide; mineral oil at 110℃; for 4h; Inert atmosphere;
70%
(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8, 96719-89-0, 118864-75-8

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

(R)-quinuclidin-3-ol
25333-42-0

(R)-quinuclidin-3-ol

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
Stage #1: (R)-quinuclidin-3-ol With sodium methylate In toluene at 5℃; Inert atmosphere; Reflux;
Stage #2: (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline In N,N-dimethyl-formamide; toluene at 60℃; Reflux;
72%
Stage #1: (R)-quinuclidin-3-ol With 1,1'-Carbonyl-di-(1,2,4-triazole); triethylamine In Isopropyl acetate at 20℃; for 2h;
Stage #2: (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline In Isopropyl acetate for 4h; Product distribution / selectivity; Heating / reflux;
propyl (1S)-1-phenyl-3,4-dihydro-2(1H)isoquinolinecarboxylate

propyl (1S)-1-phenyl-3,4-dihydro-2(1H)isoquinolinecarboxylate

(R)-quinuclidin-3-ol
25333-42-0

(R)-quinuclidin-3-ol

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
Stage #1: (R)-quinuclidin-3-ol With sodium hydride In toluene at 80℃; for 1h;
Stage #2: propyl (1S)-1-phenyl-3,4-dihydro-2(1H)isoquinolinecarboxylate In toluene for 18h; Reflux;
63.9%
(3R)-1-azabicyclo[2.2.2]octan-3-ol hydrochloride

(3R)-1-azabicyclo[2.2.2]octan-3-ol hydrochloride

(S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180468-42-2

(S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
Stage #1: (3R)-1-azabicyclo[2.2.2]octan-3-ol hydrochloride With sodium methylate at 5 - 30℃; Inert atmosphere;
Stage #2: (S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline In N,N-dimethyl-formamide; toluene at 60℃; Reflux;
51%
(S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180468-42-2

(S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline

sodium (R)-quinuclidin-3-ol

sodium (R)-quinuclidin-3-ol

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
Stage #1: sodium (R)-quinuclidin-3-ol With sodium methylate In N,N-dimethyl-formamide; toluene at 25℃; Inert atmosphere; Reflux;
Stage #2: (S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline In N,N-dimethyl-formamide; toluene at 70℃; Reflux;
50%
(S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180468-42-2

(S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline

(R)-quinuclidin-3-ol
25333-42-0

(R)-quinuclidin-3-ol

A

(1S)-3,4-dihydro-1-phenyl-2-(1H)-isoquinolinecarboxylic acid (3S)-1-azabicyclo[2.2.2]oct-3-yl ester
732228-02-3

(1S)-3,4-dihydro-1-phenyl-2-(1H)-isoquinolinecarboxylic acid (3S)-1-azabicyclo[2.2.2]oct-3-yl ester

B

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate
740780-79-4

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate

C

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8, 96719-89-0, 118864-75-8

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

D

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
With potassium 2-methylbutan-2-olate In toluene at 90℃; for 3h; Product distribution / selectivity;A 1.1%
B 3.2%
C 6%
D n/a
(S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180468-42-2

(S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline

A

(1S)-3,4-dihydro-1-phenyl-2-(1H)-isoquinolinecarboxylic acid (3S)-1-azabicyclo[2.2.2]oct-3-yl ester
732228-02-3

(1S)-3,4-dihydro-1-phenyl-2-(1H)-isoquinolinecarboxylic acid (3S)-1-azabicyclo[2.2.2]oct-3-yl ester

B

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate
740780-79-4

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate

C

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
Stage #1: (R)-quinuclidin-3-ol With sodium hydride In toluene for 0.166667h;
Stage #2: (S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline In toluene at 26 - 110℃; for 4.33333h; Product distribution / selectivity;
1-phenyl-3,4-dihydroisoquinoline
52250-50-7

1-phenyl-3,4-dihydroisoquinoline

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: NaBH4 / ethanol / 60 h / 20 °C
2: 100 percent / K2CO3 / CH2Cl2 / 20 °C
3: 89 percent / NaH / toluene / 3 h / Heating
View Scheme
Multi-step reaction with 4 steps
1.1: methanol; sodium tetrahydroborate / water / 5.42 h / 20 - 34 °C
2.1: D-tartaric acid / methanol; ethyl acetate / 2.08 h / 28 - 64 °C / Resolution of racemate
2.2: 1.17 h / pH 8 - 9
3.1: sodium carbonate / toluene / 2.17 h / 0 - 28 °C
4.1: toluene / 5 h / 55 - 115 °C
4.2: 10 h / 55 - 115 °C
View Scheme
N-phenethylbenzamide
3278-14-6

N-phenethylbenzamide

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: P2O5; POCl3 / xylene / 2.5 h / Heating
2: NaBH4 / ethanol / 60 h / 20 °C
3: 100 percent / K2CO3 / CH2Cl2 / 20 °C
4: 89 percent / NaH / toluene / 3 h / Heating
View Scheme
Multi-step reaction with 5 steps
1.1: PPA / water / 4.25 h / 14.9 - 165 °C
1.2: 0.17 h / 28 - 42 °C / pH 2.1 - 7.12
2.1: methanol; sodium tetrahydroborate / water / 5.42 h / 20 - 34 °C
3.1: D-tartaric acid / methanol; ethyl acetate / 2.08 h / 28 - 64 °C / Resolution of racemate
3.2: 1.17 h / pH 8 - 9
4.1: sodium carbonate / toluene / 2.17 h / 0 - 28 °C
5.1: toluene / 5 h / 55 - 115 °C
5.2: 10 h / 55 - 115 °C
View Scheme
(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8, 96719-89-0, 118864-75-8

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 100 percent / K2CO3 / CH2Cl2 / 20 °C
2: 89 percent / NaH / toluene / 3 h / Heating
View Scheme
Multi-step reaction with 2 steps
1.1: pyridine / toluene / 20 - 80 °C
2.1: sodium hydride / tetrahydrofuran / 0.75 h / Reflux
2.2: 1.5 h / Reflux
View Scheme
Multi-step reaction with 2 steps
1.1: bis-(p-nitrophenyl) carbonate / N,N-dimethyl-formamide / 25 - 30 °C
1.2: 3 h / 25 - 30 °C
1.3: 25 - 30 °C / pH 1 - 2
2.1: ammonium hydroxide / water / pH 9 - 10
View Scheme
(S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180468-42-2

(S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline

(R)-quinuclidin-3-ol
25333-42-0

(R)-quinuclidin-3-ol

A

(1S)-3,4-dihydro-1-phenyl-2-(1H)-isoquinolinecarboxylic acid (3S)-1-azabicyclo[2.2.2]oct-3-yl ester
732228-02-3

(1S)-3,4-dihydro-1-phenyl-2-(1H)-isoquinolinecarboxylic acid (3S)-1-azabicyclo[2.2.2]oct-3-yl ester

B

(3S)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate
774517-20-3

(3S)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate

C

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate
740780-79-4

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate

D

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
With sodium ethanolate In water; N,N-dimethyl-formamide; toluene at 20℃; for 8h; Product distribution / selectivity; Heating;
methyl (1S)-1-phenyl-3,4-dihydro-2(1H)-isoquinoline-carboxylate

methyl (1S)-1-phenyl-3,4-dihydro-2(1H)-isoquinoline-carboxylate

sodium methylate
124-41-4

sodium methylate

(R)-quinuclidin-3-ol
25333-42-0

(R)-quinuclidin-3-ol

A

(1S,3'R)-2'-methylquinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydrolsoquinoline-2-carboxylate

(1S,3'R)-2'-methylquinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydrolsoquinoline-2-carboxylate

B

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
In N,N-dimethyl-formamide; toluene for 8h;
benzyl (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate

benzyl (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate

sodium phenyl-methanolate
20194-18-7

sodium phenyl-methanolate

(R)-quinuclidin-3-ol
25333-42-0

(R)-quinuclidin-3-ol

A

(1S,3'R)-2'-benzylquinuclidin-3'-yl-1-phenyl-1,2,3,4-terahydroisoquinoline-2-carboxylate

(1S,3'R)-2'-benzylquinuclidin-3'-yl-1-phenyl-1,2,3,4-terahydroisoquinoline-2-carboxylate

B

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
In N,N-dimethyl-formamide; toluene for 8h;
C18H18ClNO2

C18H18ClNO2

(R)-quinuclidin-3-ol
25333-42-0

(R)-quinuclidin-3-ol

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide; toluene at 80 - 100℃; for 18h; Product distribution / selectivity;
(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8, 96719-89-0, 118864-75-8

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

(R)-quinuclidin-3-ol
25333-42-0

(R)-quinuclidin-3-ol

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
Stage #1: (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline; 1,1'-carbonyldiimidazole In toluene at 20℃; for 2.75h;
Stage #2: (R)-quinuclidin-3-ol With sodium hydride In N,N-dimethyl-formamide; toluene at 20 - 85℃;
(S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180468-42-2

(S)-N-carboxylic acid ethyl ester-1-phenyl-1,2,3,4-tetrahydroisoquinoline

(R)-quinuclidin-3-ol
25333-42-0

(R)-quinuclidin-3-ol

A

(1S)-3,4-dihydro-1-phenyl-2-(1H)-isoquinolinecarboxylic acid (3S)-1-azabicyclo[2.2.2]oct-3-yl ester
732228-02-3

(1S)-3,4-dihydro-1-phenyl-2-(1H)-isoquinolinecarboxylic acid (3S)-1-azabicyclo[2.2.2]oct-3-yl ester

B

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate
740780-79-4

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate

C

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
With potassium tert-butylate In toluene at 90℃; for 3 - 10h; Product distribution / selectivity;
phenyl (S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate

phenyl (S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate

(R)-quinuclidin-3-ol
25333-42-0

(R)-quinuclidin-3-ol

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl acetamide at 0 - 60℃;
Stage #1: (R)-quinuclidin-3-ol With sodium hydride In ISOPROPYLAMIDE; mineral oil at 0 - 20℃;
Stage #2: phenyl (S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate In ISOPROPYLAMIDE; toluene; mineral oil at 20 - 60℃;
(+)-(1S,3'R)-quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetrahydro-isoquinoline-2-carboxylate di-p-toluoyl-L-tartrate

(+)-(1S,3'R)-quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetrahydro-isoquinoline-2-carboxylate di-p-toluoyl-L-tartrate

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
With sodium hydrogencarbonate In water at 0 - 15℃; Product distribution / selectivity;
(+)-(1S,3'R)-quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetrahydro-isoquinoline-2-carboxylate oxalate

(+)-(1S,3'R)-quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetrahydro-isoquinoline-2-carboxylate oxalate

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
With sodium hydrogencarbonate In water; ethyl acetate at 0 - 30℃;
(+)-(1S,3'R)-quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetrahydro-isoquinoline-2-carboxylate hydrochloride

(+)-(1S,3'R)-quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetrahydro-isoquinoline-2-carboxylate hydrochloride

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
With sodium hydrogencarbonate In water; ethyl acetate at 0 - 30℃;
(S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carbonyl chloride
1195949-26-8

(S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carbonyl chloride

(R)-quinuclidin-3-ol
25333-42-0

(R)-quinuclidin-3-ol

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
Stage #1: (R)-quinuclidin-3-ol With sodium hydride In tetrahydrofuran for 0.75h; Reflux;
Stage #2: (S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carbonyl chloride In tetrahydrofuran for 1.5h; Reflux;
Stage #1: (R)-quinuclidin-3-ol With sodium hydride In tetrahydrofuran for 0.75h; Reflux;
Stage #2: (S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carbonyl chloride In tetrahydrofuran for 1.5h; Reflux;
2-(1H-imidazole-2-ylcarbonyl)-(1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
1029430-94-1

2-(1H-imidazole-2-ylcarbonyl)-(1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

(R)-quinuclidin-3-ol
25333-42-0

(R)-quinuclidin-3-ol

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
Stage #1: 2-(1H-imidazole-2-ylcarbonyl)-(1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline With titanium(IV) isopropylate In tetrahydrofuran at 20℃; for 0.5h;
Stage #2: (R)-quinuclidin-3-ol With sodium hydride In tetrahydrofuran Product distribution / selectivity; Reflux;
(3R)-1-azabicyclo[2.2.2]oct-3-yl 4-nitrophenyl carbonate
1243274-81-8

(3R)-1-azabicyclo[2.2.2]oct-3-yl 4-nitrophenyl carbonate

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8, 96719-89-0, 118864-75-8

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 25 - 30℃; Product distribution / selectivity;
solifenacin succinate

solifenacin succinate

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
With ammonia In water; toluene pH=9 - 10;
sodium ethanolate
141-52-6

sodium ethanolate

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8, 96719-89-0, 118864-75-8

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

(R)-quinuclidin-3-ol
25333-42-0

(R)-quinuclidin-3-ol

A

(1S,3'R)-2'-ethylquinuclidine-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate

(1S,3'R)-2'-ethylquinuclidine-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate

B

solifenacin
242478-37-1

solifenacin

Conditions
ConditionsYield
Stage #1: chloroformic acid ethyl ester; (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline With potassium carbonate In water; toluene at 10 - 25℃; for 2h;
Stage #2: sodium ethanolate; (R)-quinuclidin-3-ol In N,N-dimethyl-formamide; toluene at 20℃; for 8h;
Stage #3: With hydrogenchloride; potassium carbonate more than 3 stages;
succinic acid
110-15-6

succinic acid

solifenacin
242478-37-1

solifenacin

solifenacin succinate

solifenacin succinate

Conditions
ConditionsYield
In toluene at 20 - 50℃; Product distribution / selectivity;100%
In ethyl acetate at 20 - 80℃; for 10h;94.2%
In ethyl acetate; acetone for 2h; Reflux;91.9%
(1S)-3,4-dihydro-1-phenyl-2-(1H)-isoquinolinecarboxylic acid (3S)-1-azabicyclo[2.2.2]oct-3-yl ester
732228-02-3

(1S)-3,4-dihydro-1-phenyl-2-(1H)-isoquinolinecarboxylic acid (3S)-1-azabicyclo[2.2.2]oct-3-yl ester

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate
740780-79-4

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate

succinic acid
110-15-6

succinic acid

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8, 96719-89-0, 118864-75-8

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

solifenacin
242478-37-1

solifenacin

A

(1S)-3,4-dihydro-1-phenyl-2-(1H)-isoquinolinecarboxylic acid (3S)-1-azabicyclo[2.2.2]oct-3-yl ester succinate
862207-71-4

(1S)-3,4-dihydro-1-phenyl-2-(1H)-isoquinolinecarboxylic acid (3S)-1-azabicyclo[2.2.2]oct-3-yl ester succinate

B

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate succinate
862207-70-3

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate succinate

C

1-(S)-phenyl-1,2,3,4-tetrahydroisoquinoline succinate

1-(S)-phenyl-1,2,3,4-tetrahydroisoquinoline succinate

D

solifenacin succinate

solifenacin succinate

Conditions
ConditionsYield
In isopropyl alcohol at 20℃;A 0.33%
B 0.17%
C 0.07%
D 89%
succinic acid
110-15-6

succinic acid

solifenacin
242478-37-1

solifenacin

(1S)-(3R)-1-azabicyclo[2.2.2]oct-3-yl 3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate succinate

(1S)-(3R)-1-azabicyclo[2.2.2]oct-3-yl 3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate succinate

Conditions
ConditionsYield
In isopropyl alcohol at 20℃;89%
In ethanol; ethyl acetate at 20℃; Reflux;
In ethanol at 70 - 75℃;
L-Tartaric acid
87-69-4

L-Tartaric acid

solifenacin
242478-37-1

solifenacin

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate hydrogen L-tartrate
1035547-81-9

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate hydrogen L-tartrate

Conditions
ConditionsYield
In methanol; isopropyl alcohol at 20℃;89%
solifenacin
242478-37-1

solifenacin

(1'S,3R)-3-[[(1'-phenyl-1',2',3',4'-tetrahydro-2'-isoquinolyl)carbonyl]oxy]quinuclidine 1-oxide
180272-28-0

(1'S,3R)-3-[[(1'-phenyl-1',2',3',4'-tetrahydro-2'-isoquinolyl)carbonyl]oxy]quinuclidine 1-oxide

Conditions
ConditionsYield
With sodium hydrogencarbonate; 3-chloro-benzenecarboperoxoic acid In dichloromethane at 10 - 20℃; for 1h;83%
(1S)-3,4-dihydro-1-phenyl-2-(1H)-isoquinolinecarboxylic acid (3S)-1-azabicyclo[2.2.2]oct-3-yl ester
732228-02-3

(1S)-3,4-dihydro-1-phenyl-2-(1H)-isoquinolinecarboxylic acid (3S)-1-azabicyclo[2.2.2]oct-3-yl ester

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate
740780-79-4

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate

L-Tartaric acid
87-69-4

L-Tartaric acid

solifenacin
242478-37-1

solifenacin

A

(3S)-1-azabicyclo[2.2.2]oct-3-yl (1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate tartrate

(3S)-1-azabicyclo[2.2.2]oct-3-yl (1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate tartrate

B

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate hydrogen L-tartrate
1035547-81-9

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate hydrogen L-tartrate

C

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate tartrate

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate tartrate

Conditions
ConditionsYield
In methanol; isopropyl alcohol at 20℃;A 0.6%
B 79%
C 1.1%
solifenacin
242478-37-1

solifenacin

Solifenacin hydrochloride

Solifenacin hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In methanol; butanone at 20℃; Purification / work up;63%
With hydrogenchloride In methanol; butanone at 20℃;63%
With hydrogenchloride In ethanol; ethyl acetate
With hydrogenchloride In ethanol; water at 20℃; Product distribution / selectivity;
oxalic acid
144-62-7

oxalic acid

solifenacin
242478-37-1

solifenacin

A

C2H2O4*C18H19NO2

C2H2O4*C18H19NO2

B

(S)-((R)-quinuclidin-3-yl) 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate monooxalate

(S)-((R)-quinuclidin-3-yl) 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate monooxalate

C

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline oxalate

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline oxalate

D

C2H2O4*C23H26N2O2

C2H2O4*C23H26N2O2

E

C2H2O4*C23H26N2O2

C2H2O4*C23H26N2O2

Conditions
ConditionsYield
In ethanol
succinic acid
110-15-6

succinic acid

solifenacin
242478-37-1

solifenacin

A

(1S)-3,4-dihydro-1-phenyl-2-(1H)-isoquinolinecarboxylic acid (3S)-1-azabicyclo[2.2.2]oct-3-yl ester succinate
862207-71-4

(1S)-3,4-dihydro-1-phenyl-2-(1H)-isoquinolinecarboxylic acid (3S)-1-azabicyclo[2.2.2]oct-3-yl ester succinate

B

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate succinate
862207-70-3

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate succinate

C

solifenacin succinate

solifenacin succinate

Conditions
ConditionsYield
In ethanol; ethyl acetate at 0 - 50℃; Product distribution / selectivity;
(3S)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate
774517-20-3

(3S)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate

solifenacin
242478-37-1

solifenacin

A

(1S,3'S)-quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monohydrochloride

(1S,3'S)-quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monohydrochloride

B

Solifenacin hydrochloride

Solifenacin hydrochloride

C

(1R,3'R)-quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monohydrochloride

(1R,3'R)-quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monohydrochloride

D

C18H19NO2*ClH

C18H19NO2*ClH

E

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline hydrochloride

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In ethanol; ethyl acetate Product distribution / selectivity;

Solifenacin Specification

The Solifenacin is an organic compound with the formula C23H26N2O2. The IUPAC name of this chemical is 1-azabicyclo[2.2.2]octan-3-yl(1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate. With the CAS registry number 242478-37-1, it is also named as 2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester, (1S)-. Besides, it is used in the treatment of overactive bladder with or without urge incontinence.

Physical properties about Solifenacin are: (1)ACD/LogP: 4.159; (2)ACD/LogD (pH 5.5): 1.20; (3)ACD/LogD (pH 7.4): 2.53; (4)ACD/BCF (pH 5.5): 1.00; (5)ACD/BCF (pH 7.4): 20.09; (6)ACD/KOC (pH 5.5): 4.74 ; (7)ACD/KOC (pH 7.4): 102.71; (8)#H bond acceptors: 4; (9)#Freely Rotating Bonds: 3; (10)Index of Refraction: 1.649; (11)Molar Refractivity: 105.823 cm3; (12)Molar Volume: 290.574 cm3; (13)Polarizability: 41.951 10-24cm3; (14)Surface Tension: 57.4669990539551 dyne/cm; (15)Density: 1.247 g/cm3; (16)Flash Point: 259.526 °C ; (17)Enthalpy of Vaporization: 77.52 kJ/mol; (18)Boiling Point: 505.515 °C at 760 mmHg

You can still convert the following datas into molecular structure:
(1)SMILES: O=C(O[C@@H]2C1CCN(CC1)C2)N5[C@@H](c3ccccc3)c4ccccc4CC5
(2)InChI: InChI=1/C23H26N2O2/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19/h1-9,18,21-22H,10-16H2/t21-,22-/m0/s1(3)InChIKey: FBOUYBDGKBSUES-VXKWHMMOBQ
(4)Std. InChI: InChI=1S/C23H26N2O2/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19/h1-9,18,21-22H,10-16H2/t21-,22-/m0/s1
(5)Std. InChIKey: FBOUYBDGKBSUES-VXKWHMMOSA-N

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View